Corticoids in Severe Community-Acquired Pneumonia (CAP)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of glucocorticoids as an adjuvant therapy
in patients with severe community-acquired pneumonia (CAP) (Fine V). The hypothesis of the
study is that glucocorticoids can modulate the excessive inflammatory response in patients
with severe CAP without any significant side effects, showing a benefit in the percentage of
non-response to the empiric antimicrobial treatment.